Semaglutide Price: List Cost, Insurance, and Savings

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Welcome to the PlexusDx Education Hub, where GLP-1 science gets unpacked one honest question at a time. Browse the full Peptides & GLP-1 library to see how the topics connect.

Few GLP-1 questions generate more confusion than price, because the number quoted online and the number paid at the pharmacy counter are rarely the same. As of April 2026 the semaglutide price picture has several moving parts: a published list figure, insurance and prior-authorization rules, manufacturer savings programs, pharmacy discounts, and the separate world of compounded formulations. This page separates those threads so the quoted numbers make sense.

Before parsing any single quote, it helps to remember that GLP-1 pricing is layered rather than fixed. The same medication can carry several very different prices at once depending on who is asking, which plan is involved, and where the prescription is filled. That layering is the source of most of the confusion people encounter online.

The list price you will see quoted

Semaglutide list price runs roughly $968 to $1,029 per month at U.S. list as of April 2026, based on Novo Nordisk published pricing. That figure is best understood as the sticker before anything else happens. It sits ahead of insurance adjustments, negotiated rebates, manufacturer savings cards, and pharmacy-level pricing, so most insured patients never pay it directly. What a specific person pays depends on plan design, formulary placement, prior authorization, and the indication written on the prescription.

How insurance and prior authorization reshape the number

Whether a commercial plan covers semaglutide hinges on whether the prescription is written for an FDA-approved indication and on that plan's own formulary and prior-authorization criteria. Many commercial plans cover GLP-1 receptor agonists for type 2 diabetes. Coverage for chronic weight management is far more variable, is frequently gated behind BMI-based prior authorization, and is excluded outright by some plans. Medicare does not cover FDA-approved weight-management drugs for weight alone as of April 2026, though cardiovascular-indication coverage exists for certain products. The only reliable answer comes from checking directly with your plan.

Savings cards, coupons, and their fine print

Novo Nordisk publishes a manufacturer savings card program that can meaningfully lower monthly out-of-pocket cost for eligible commercially insured patients. Eligibility typically excludes people on Medicare, Medicaid, TRICARE, and other government-funded insurance, and the cards carry monthly and annual caps that change over time, so terms should be verified on the manufacturer site at the moment of fill. Independent discount platforms such as GoodRx and SingleCare publish separate coupon prices that vary by pharmacy, which is why quotes for the same drug can differ block to block.

The compounding chapter of 2024 and 2025

During FDA-declared shortages of semaglutide and tirzepatide, 503A compounding pharmacies legally produced compounded formulations of these molecules. The FDA resolved the semaglutide shortage in late 2024 and the tirzepatide shortage in early 2025, which narrowed the compounding window without ending all legitimate compounding-pharmacy activity. Compounded semaglutide and tirzepatide remain available through licensed pathways where clinically justified. These products are not identical to FDA-approved brand medications and are priced on their own terms.

What genetics adds before you weigh the spend

Cost is one input; biology is another that people skip. Inherited variants in FTO, GLP1R, and MC4R shape baseline appetite regulation and energy-balance biology, the terrain any GLP-1 decision plays out on. They do not predict what a given compound will cost or how it will perform for you. The Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights, offering upstream context before money is committed. PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols, including a Semaglutide Injection option, with per-protocol pricing published on each product page.

Taken together, these moving parts explain why two people can be quoted wildly different figures for the same medication. Rather than chasing a single headline number, the more useful exercise is to map your own plan, indication, and pharmacy options with a provider and pharmacist before assuming what a fill will cost.

Frequently Asked Questions

How much does semaglutide cost per month?

List price is approximately $968 to $1,029 per month at U.S. list as of April 2026, per Novo Nordisk published pricing. Insurance, savings cards, and pharmacy-level pricing can move the counter total substantially in either direction, so confirm the current figure with the dispensing pharmacy before the prescription is filled.

Will insurance cover semaglutide?

It depends on the plan, its formulary, the FDA indication on the prescription, and prior-authorization criteria. Many commercial plans cover GLP-1 receptor agonists for type 2 diabetes, while chronic weight-management coverage is more variable. Medicare does not cover weight-management indications for weight alone as of April 2026.

Are there coupons or savings cards?

Novo Nordisk publishes a manufacturer savings card for commercially insured patients who meet eligibility rules, and platforms like GoodRx publish separate discount prices. Government-insurance patients are typically excluded from manufacturer cards. Because caps and terms change, verify current details on the manufacturer site at the time of fill.

Are lower-cost alternatives available?

Licensed compounding pharmacies produce compounded semaglutide and tirzepatide at price points separate from the FDA-approved brands. Compounded products are legally and factually distinct, not generics. PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols, with per-protocol pricing published on each product page.

Keep exploring the PlexusDx Education Hub for more evidence-first GLP-1 guidance. Return to the education hub.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.